{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:53:56Z","timestamp":1792162436318,"version":"4.4.0"},"reference-count":45,"publisher":"EDITORA SCIENTIFIC","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. J. Psychiatry"],"DOI":"10.1590\/1516-4446-2017-0021","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T16:59:06Z","timestamp":1542819546000},"page":"218-224","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer\u2019s disease in Brazil"],"prefix":"10.47626","volume":"41","author":[{"given":"Luciana R.","family":"da Silva","sequence":"first","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro (UERJ), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cid M.M.","family":"Vianna","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro (UERJ), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela B.G.","family":"Mosegui","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense (UFF), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio A.F.","family":"Peregrino","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Ci\u00eancias Radiol\u00f3gicas (IBRAG), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska","family":"Marinho","sequence":"additional","affiliation":[{"name":"Instituto de Psiquiatria, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerson","family":"Laks","sequence":"additional","affiliation":[{"name":"Instituto de Psiquiatria, Brazil; Universidade do Grande Rio (BioTrans-Unigranrio), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27448","published-online":{"date-parts":[[2019,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu C","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"ref2","series-title":"Dementia: a public health priority","year":"2012"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.6061\/clinics\/2013(08)13","article-title":"Prevalence of dementia subtypes in a developing country: a clinicopathological study","volume":"68","author":"Grinberg LT","year":"2013","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1017\/S1041610209009430","article-title":"Prevalence of dementia in Latin America: a collaborative study of population-based cohorts","volume":"21","author":"Nitrini R","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"ref5","series-title":"Diagn\u00f3stico cl\u00ednico na doen\u00e7a de Alzheimer","first-page":"173","volume-title":"Dem\u00eancia e transtornos cognitivos em idosos","author":"Bottino CM","year":"2006"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.archger.2010.02.003","article-title":"Incidence of dementia and cause of death in elderly Japanese emigrants to Brazil before World War II","volume":"52","author":"Meguro K","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0891988709332942","article-title":"Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil","volume":"22","author":"Chaves ML","year":"2009","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1041610210000785","article-title":"Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease","volume":"23","author":"Bergvall N","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"ref9","first-page":"3827","article-title":"[The acquisition of medication to treat Alzheimer's disease in Brazil: an analysis of federal purchases, 2008-2013]","volume":"20","author":"da Costa RD","year":"2015","journal-title":"Cienc Saude Colet"},{"key":"ref10","series-title":"World Alzheimer Report 2010. The Global Economic Impact of Dementia [Internet]","year":"2010"},{"key":"ref11","series-title":"Portaria n\u00b0 843, de 31 de outubro de 2002. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Doen\u00e7a de Alzheimer [Internet]. Di\u00e1rio Oficial da Uni\u00e3o, 4 novembro 2013","year":"2018"},{"key":"ref12","first-page":"11","article-title":"Efic\u00e1cia do tratamento farmacol\u00f3gico da dem\u00eancia","volume":"24","author":"Flicker L","year":"2002","journal-title":"Rev Bras Psiquiatr"},{"key":"ref13","series-title":"Neuropsychopharmacology: the fifth generation of progress","first-page":"1267","volume-title":"Cost-effectiveness of therapeutics for Alzheimer disease","author":"Manca A","year":"2002"},{"key":"ref14","series-title":"Gastos com medicamentos para tratamento da Doen\u00e7a de Alzheimer pelo Minist\u00e9rio da Sa\u00fade, 2007-2011 [Internet]","author":"Lima MG","year":"2018"},{"key":"ref15","first-page":"e00060615","article-title":"[Access to medicines for Alzheimer's disease provided by the Brazilian Unified National Health System in Minas Gerais State, Brazil]","volume":"32","author":"Almeida-Brasil CC","year":"2016","journal-title":"Cad Saude Publica"},{"key":"ref16","first-page":"189","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein MF","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000048631","article-title":"Economic evaluation of donepezil treatment for Alzheimer\u2019s disease in Japan","volume":"13","author":"Ikeda S","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2174\/156720512803569046","article-title":"Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS","volume":"9","author":"Spackman DE","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0149-2918(00)89012-8","article-title":"Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine","volume":"22","author":"Hauber AB","year":"2000","journal-title":"Clin Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00019053-199916020-00005","article-title":"Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach","volume":"16","author":"Fenn P","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0149-2918(00)80025-9","article-title":"The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model","volume":"21","author":"Jonsson L","year":"1999","journal-title":"Clin Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.52.6.1138","article-title":"Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease","volume":"52","author":"Neumann PJ","year":"1999","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease","volume":"39","author":"Morris JC","year":"1989","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.0.CO;2-E","article-title":"Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil","volume":"13","author":"Stewart A","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref25","first-page":"225","article-title":"The prevalence and the course of neuropsychiatric symptoms in patients with dementia","volume":"22","author":"Bergh S","year":"2012","journal-title":"Nor Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S0047-20852007000200002","article-title":"Tratando os sintomas comportamentais e psicol\u00f3gicos da dem\u00eancia (SCPD)","volume":"56","author":"Camelli P","year":"2007","journal-title":"J Bras Psiquiatr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2006.04.020","article-title":"Frontal functions in depressed and nondepressed Parkinson's disease patients: impact of severity stages","volume":"149","author":"Silberman CD","year":"2007","journal-title":"Psychiatry Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/gps.1567","article-title":"Risk factors for neuropsychiatric symptoms in dementia: the cache county study","volume":"21","author":"Steinberg M","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.JGP.0000218218.47279.db","article-title":"Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity","volume":"14","author":"Tatsch MF","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/gps.1316","article-title":"The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study","volume":"20","author":"Aalten P","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp-2014-308112","article-title":"Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis","volume":"86","author":"Wang J","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref32","first-page":"481","article-title":"Burden of Alzheimer's disease and association with negative health outcomes","volume":"15","author":"Malone DC","year":"2009","journal-title":"Am J Manag Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJM199409293311301","article-title":"A multifactorial intervention to reduce the risk of falling among elderly people living in the community","volume":"331","author":"Tinetti ME","year":"1994","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/1414-462X201500010011","article-title":"Fatores associados ao custo das interna\u00e7\u00f5es hospitalares por doen\u00e7as infecciosas em idosos em hospital de refer\u00eancia na cidade do Natal, Rio Grande do Norte","volume":"23","author":"Piuvezam G","year":"2015","journal-title":"Cad Saude Colet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jval.2013.10.009","article-title":"Raina P; Canadian Willingness-to-Pay Study Group, Raina P. Health utility scores in Alzheimer\u2019s disease: differences based on calculation with American and Canadian preference weights","volume":"17","author":"Oremus M","year":"2014","journal-title":"Value Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/156720510791162430","article-title":"Cross sectional observational study on the societal costs of Alzheimer\u2019s disease","volume":"7","author":"Mesterton J","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.wad.0000201851.52707.c9","article-title":"Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL","volume":"20","author":"Jonsson L","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11136-005-4364-8","article-title":"Utility-based quality of life measures in Alzheimer\u2019s disease","volume":"15","author":"Naglie G","year":"2006","journal-title":"Qual Life Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-12-2","article-title":"Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer\u2019s disease in Germany using discrete event simulation","volume":"12","author":"Hartz S","year":"2012","journal-title":"BMC Neurol"},{"key":"ref40","series-title":"Medicamentos e OPM do SUS [Internet]","year":"2016"},{"key":"ref41","series-title":"Portal de compras do Governo Federal [Internet]","year":"2016"},{"key":"ref42","series-title":"Diretrizes metodol\u00f3gicas, diretriz de avalia\u00e7\u00e3o econ\u00f4mica [Internet]","year":"2014"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram MY","year":"2016","journal-title":"Bull World Health Organ"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10010","article-title":"The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease","volume":"10","author":"Loveman E","year":"2006","journal-title":"Health Technol Assess"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000066669","article-title":"An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial","volume":"15","author":"Wimo A","year":"2003","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Brazilian Journal of Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v41n3\/1516-4446-rbp-1516444620170021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:12:02Z","timestamp":1654531922000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462019000300218&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["S1516-44462019000300218"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2017-0021","relation":{},"ISSN":["1809-452X","1516-4446"],"issn-type":[{"value":"1809-452X","type":"electronic"},{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}